Drawing for PROCLARIX

USPTO serial 79279926

PROCLARIX

Reviewed by CopyMark Law Group

Reg. 6144400Status 739Renewal
Filing date
Status date
Registration date
Sep 8, 2020
Examiner
MIRANDA, JOHN
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with PROCLARIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*

Plus Government fees of $2,125

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew N. Spivak

Andrew N. Spivak Mosaic Legal Group, PLLC4300 Fordham Road, NW, Suite 250Washington, DC 20016-1950United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical substances and preparations used in oncology, namely, pharmaceutical preparations for treating cancer; sanitary preparations for medical purposesACTIVE—
009Downloadable software for use in oncology medical practice applicationsACTIVE—
010Testing apparatus for medical use, namely, blood testing apparatus; blood testing apparatus; medical apparatus and instruments, namely, medical apparatus for diagnostic testing in connection with cancer; urological apparatus and instruments, namely, medical diagnostic apparatus for use in testing urinary tract infections; diagnostic apparatus for medical use, namely, medical apparatus for diagnostic testing in connection with cancerACTIVE—
042Scientific and technological services, namely, research and design services in the field of computers and software; industrial analysis and research services, namely, industrial research in the fields of computers and software; design and development of computers and software; providing temporary use of online, non-downloadable software for use in oncology medical practice applicationsACTIVE—
044Medical services; advisory services relating to medical apparatus and instruments; medical and pharmaceutical consultation services, namely, services provided by consultants regarding pharmaceutical and medical products; medical analysis services for cancer diagnosis; medical analysis services for cancer diagnosis and prognosis; medical services regarding human blood collection, treatment and processing; provision of information in the field of cancer prevention, screening, diagnosis and treatment; provision of information in the field of medicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Oct 6, 2026C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Oct 5, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 4, 2026ES75TEAS SECTION 71 & 15 RECEIVED—
Sep 8, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 24, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 30, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 30, 2020FIMPFINAL DISPOSITION PROCESSED—
Dec 8, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 8, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 23, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 5, 2020RFNTREFUSAL PROCESSED BY IB—
Jun 3, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 15, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 15, 2020XAECEXAMINER'S AMENDMENT ENTERED—
May 15, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 15, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
May 15, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
May 9, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 8, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2020CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 1, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 31, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 31, 2020RFRRREFUSAL PROCESSED BY MPU—
Mar 17, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 16, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2020DOCKASSIGNED TO EXAMINER—
Mar 10, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 4, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 27, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance